D. S. Krupashankar

Efficacy and safety of itolizumab, a novel anti-CD6 monoclonal antibody, in patients with moderate to severe chronic plaque psoriasis: Results of a double-blind, randomized, placebo-controlled, phase-III study

D. S. Krupashankar, Sunil Dogra, Mahendra M. Kura et al. · Journal of the American Academy of Dermatology · 2014 · 109 citations

Phase-iii Study, Autoimmune Disease, Immunology +7

Suction blister grafting for stable vitiligo using pulsed erbium:YAG laser ablation for recipient site

Mukta Sachdev, D. S. Krupashankar · International Journal of Dermatology · 2000 · 37 citations

Standard guidelines of care: CO2 laser for removal of benign skin lesions and resurfacing.

D. S. Krupashankar · PubMed · 2008 · 21 citations

Oral hyposensitization in <i>Parthenium</i> dermatitis

C. R. Srinwas, D. S. Krupashankar, K. K. Singh et al. · Contact Dermatitis · 1988 · 17 citations

Oral Biology, Oral Hyposensitization, Oral Medicine +6